Team:Harvard/fences/parts

From 2010.igem.org

(Difference between revisions)
Line 36: Line 36:
<tr><td>Barstar</td><td>Protein inhibitor of Barnase</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f2">link</a></td></tr>
<tr><td>Barstar</td><td>Protein inhibitor of Barnase</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f2">link</a></td></tr>
<tr><td>LacIN</td><td>Lac Inhibitor with Nuclear Localization sequence - transcriptional inhibitor of the Act2LacO promoter</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f3">link</a></td></tr>
<tr><td>LacIN</td><td>Lac Inhibitor with Nuclear Localization sequence - transcriptional inhibitor of the Act2LacO promoter</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f3">link</a></td></tr>
-
<tr><td>RXRLc-VP16</td><td> Fusion protein of Locust Retinoic Acid Receptor and VP16 activation domain - binds EcR-Gal4 in presence of Methoxyfenozide</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f4">link</a></td></tr>
+
<tr><td>RXRLc</td><td> Part of the Locust Retinoic Acid Receptor and VP16 activation domain fusion protein. RXRLc binds EcR in presence of Methoxyfenozide</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f4">link</a></td></tr>
-
<tr><td>EcR-Gal4</td><td> Fusion protein of Ecdysone receptor and Gal4 DNA binding domain - binds RXRLc-VP16 and initiates transcription downstream of Gal Upstream Activating Sequence in presence of Methoxyfenozide </td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f5">link</a></td></tr>
+
<tr><td>VP16</td><td> Part of the Locust Retinoic Acid Receptor and VP16 activation domain fusion protein. VP16 recruits transcription factors, and when colocalized with the Gal4 Upstream Activating Sequence initiates transcription downstream of the 5xGal435s promoter.</td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f5">link</a></td></tr>
 +
<tr><td>Ecdysone Receptor</td><td> Part of the fusion protein of Ecdysone receptor and Gal4 DNA binding domain. Ecdysone receptor binds RXRLc-VP16 in presence of Methoxyfenozide </td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f6">link</a></td></tr>
 +
<tr><td>Gal4 DNA binding domain</td><td> Part of the Gal4-EcR fusion protein. Gal4 associates with the Gal4 upstream activating sequence, and when RXRLc-VP16 is bound, it localizes VP16 to the Gal4UAS35s promoter resulting in transcription downstream. </td><td>chloramphenicol</td><td><a href="https://2010.igem.org/Team:Harvard/f7">link</a></td></tr>
</table>
</table>

Revision as of 16:52, 25 October 2010


parts and primers

Parts

NameDescriptionResistanceSequence
Barnase Fatal gene for the genetic fence chloramphenicollink
BarstarProtein inhibitor of Barnasechloramphenicollink
LacINLac Inhibitor with Nuclear Localization sequence - transcriptional inhibitor of the Act2LacO promoterchloramphenicollink
RXRLc Part of the Locust Retinoic Acid Receptor and VP16 activation domain fusion protein. RXRLc binds EcR in presence of Methoxyfenozidechloramphenicollink
VP16 Part of the Locust Retinoic Acid Receptor and VP16 activation domain fusion protein. VP16 recruits transcription factors, and when colocalized with the Gal4 Upstream Activating Sequence initiates transcription downstream of the 5xGal435s promoter.chloramphenicollink
Ecdysone Receptor Part of the fusion protein of Ecdysone receptor and Gal4 DNA binding domain. Ecdysone receptor binds RXRLc-VP16 in presence of Methoxyfenozide chloramphenicollink
Gal4 DNA binding domain Part of the Gal4-EcR fusion protein. Gal4 associates with the Gal4 upstream activating sequence, and when RXRLc-VP16 is bound, it localizes VP16 to the Gal4UAS35s promoter resulting in transcription downstream. chloramphenicollink

Promoters

NameDescriptionActive conditionsResistanceSequence
pENT CUP Constitutive Plant PromoterConstitutivechloramphenicol
5xGal UAS 5 time repeat of Gal4 upstream activating sequenceOn in presense of dimerized EcR-Gal and RXRLc-VP16chloramphenicol
Act2lacOActin2 promoter with Lac Inhibitor responsive sites (Lac O sitesConstitutive, inhibited by LacINchloramphenicol


Primers

NameDescriptionSequence
Arp2mutForwardPoint mutagenesis to remove restriction enzyme site5'-CAA GAA GCT TGA CTT GTC TAC GAA CTC TTC CAT TTC-3'
Arp2mutReversePoint mutagenesis to remove restriction enzyme site5'-GAA ATG GAA GAA CTC GTA GAC AAG TCA AGC TCC TTG-3'
Exp2MutForwardPoint mutagenesis to remove restriction enzyme site5'-CCT ACA CAC GGA ACT CCT GGA AAT TAA GAC CG-3'
Exp2mutReversePoint mutagenesis to remove restriction enzyme site5'-CGG TCT TAA TTT CCA GGA ACT CCG TGT GTA GG-3'
Bam.Gal4.FwdAttaching BamH1 sites to Gal4 in preparation for yeast vector ligation5'-AAA AGG ATC CAA AAA AAT GAA GCT ACT GTC TTC TAT C-3'
HmRXR.Hind.RevAttaching HindIII sites to HmRXR in preparation for yeast vector ligation5'-AAT TAA GCT TGG ATC CCT CGA GCT GCA GC-3'
LcRXR.Hind.RevAttaching HindIII sites to LcRXR in preparation for yeast vector ligation5'-GAT GAA GCT TGG ATC CCT CGA GCT GC-3'
VP16.Hind.FwdAttaching HindIII sites to VP16 in preparation for yeast vector ligation5'-AAA AAA GCT TAA AAA AAT GGC TAG CGC CGC CAC CAT G-3'
VP16.RevReverse primer for VP16.Hind.Fwd PCR - no modification5'-CTG CAG CGG CCG CTA CTA GTG CCC TTG GAA TTG ACG AGT AC-3'
NLS.serine.BB.FwdOligo to anneal NLS, with one bp difference to avoid self-complementarity 5'-/5Phos/CTA GAA GTT CTG TTG TTC ATC CTA AGA AGA AGA GAA AGG TTT GAA CTA GTA GCG GCC GCT GCA-3'
NLS.serine.BB.RevComplement to NLS.serine.BB.Fwd. for NLS annealing5'-/5Phos/GCG GCC GCT ACT AGT TCA AAC CTT TCT CTT CTT CTT AGG ATG AAC AAC AGA ACT T-3'
Fwd.BB.AtEXP2for amplification/extraction of an arabidopsis germination-specific promoter5'-CCT TTC TAG ACC TGG TGT GGT TTC TTT G-3'
Rev.BB.AtEXP2for amplification/extraction of an arabidopsis germination-specific promoter5'-AAG GCT GCA GCG GCC GCT ACT GAT ATT TGC TGA TGG GCT AAA G-3'
Fwd.BB.AtARP2for amplification/extraction of the arabidopsis ARP2 promoter5'-CCT TTC TAG ACC ATC ACA TAT TTG TAG AAT G-3'
Rev.BB.AtARP2for amplification/extraction of the arabidopsis ARP2 promoter5'-AAG GCT GCA GCG GCC GCT ACT AGT CTT CTC CGA TTT CTA TAG AG-3'
barnase2.BB.fwdaddition of biobrick sites/ends to barnase gene5'-CCT TTC TAG AAT GGT ACC GGT TAT CAA CAC G-3'
BB.Barnase.Revaddition of biobrick sites/ends to barnase gene5'-AAG GCT GCA GCG GCC GCT ACT AGT TTA TCT GAT TTT TGT AAA GGT CTG-3'
NLS.BB.Fwdaddition of biobrick sites/ends to the arabidopsis NLS5'-/5Phos/CTA GAT CTT CTG TTG TTC ATC CAT AGA AGA AGA GAA AGG TTT GAA CTA GTA GCG GCC GCT GCA-3'
NLS.BB.Revaddition of biobrick sites/ends to the arabidopsis NLS5'/5Phos/GCG GCC GCT ACT AGT TCA AAC CTT TCT CTT CTT CTT AGG ATG AAC AAC AGA AGA-3'
LacIn.BB.FwdAddition of NLS to the Lac Inhibitor gene to produce LacIN5'-CCT TGA ATT CGC GGC CGC ATC TAG AAT GAA AC AGT AAC GTT ATA CGA TGT C-3'
LacIN.BB.RevAddition of NLS to the Lac Inhibitor gene to produce LacIN5' AAG GTC GCA GCA GCG GCC GCT ACT AGT TCA AAC CTT TCT CTT CTT CTT AGG ATG AAC AAC AGA AGA CTG CCC GCT TTC CAG TCG GGA AA-3'
BB.Gal4DBD.FwdAdding biobrick sites to Gal4 DNA Binding Domain5'-CTT TTC TAG AAT GAA GCT ACT GTC TTC TAT C-3'
BB.Gal4DBD.RevAdding biobrick sites to Gal4 DNA Binding Domain5'-AAG GCT GCA GCG GCC GCT ACT AGT CGA TAC AGT CAA CTG TCT TTG-3'
BB.Barstar.Fwdaddition of biobrick sites/ends to barstar gene5'CCT TTC TAG AAT GAA AAA AGC AGT CAT TAA C-3'
BB.Barstar.Revaddition of biobrick sites/ends to barstar gene5'-AAG GCT GCA GCG GCC GCT ACT AGT TTA AGA AAG TATA GAT GGT GAT GTC-3'